"We are proud to announce the launch of the bilevel range of products on the S9™ platform, our latest and most innovative flow generator system for treating respiratory disorders including sleep-disordered breathing. Now, for the first time in our history, health care providers have one platform that can treat obstructive sleep apnea, central sleep apnea and Cheyne–Stokes respiration, as well as provide noninvasive ventilation for patients requiring ventilatory support," said Michael Farrell, Sr. Vice President of the Global Sleep Business Unit at ResMed. "Our goal is to increase patients' quality of life by providing comfortable, quiet, easy-to-use and highly effective treatment. A critical element of successful treatment is long-term adherence to therapy. Since its launch just over a year ago, the S9 Series has been able to help physicians and respiratory therapists achieve that goal—driving therapeutic compliance by patients around the globe."
Historically, patients' ability to comply with sleep or respiratory therapies was negatively affected by noisy devices, nasal dryness/congestion and breathing discomfort. To combat these negative effects and increase patients' ability to adhere to respiratory therapy, ResMed's new generation of bilevel devices build on features that are crucial to maintaining and increasing overall patient compliance.
"Our S9 Series is already recognized as the most advanced sleep therapy system in the market, offering more than any other device in terms of comfort, innovation and style. Now that our bilevel devices are part of the S9 family, it allows clinicians to provide the same high level of quality treatment to a wider range of sleep apnea sufferers, including patients who are having difficulty staying compliant on therapy," stated Drew Terry, Sr. Director of Product Management at ResMed.
"Understanding that bilevel users have unique needs, we developed the S9 VPAP platform to help patients overcome the challenges of noncompliance by giving them tools and technologies to proactively manage their own therapy," added Terry. "The Enhanced Easy-Breathe technology and Climate Control system give them control over their own comfort settings. The sleek and intuitive design makes it easy to set up and use. And it provides daily encouragement by allowing them to view their ongoing therapy progress with the Sleep Quality Indicator."
S9 VPAPs are the only bilevel devices that offer Climate Control, a state-of-the-art humidification system that intelligently adapts to environmental conditions to deliver optimal pressure and temperature. Complemented by ResMed's exclusive ClimateLine™ heated tube, it protects patients from rainout without compromising humidity or temperature levels.
Early market trials have already returned positive feedback from patients, who commented on the quietness and comfort of the VPAP™. "I loved the lightweight tubing with ClimateLine," commented Tracy Nasca, Vice President of TalkAboutSleep.com and a long-time bilevel user. "On the first night, I had to keep checking to see if my machine was on and working because it was so quiet. Honestly, it was the most pleasant experience I've ever had using bilevel since my initiation in 1990."
Home medical equipment (HME) providers have also seen a noticeable improvement in compliance, commenting on the dramatic difference their patients have experienced with VPAP. "My patients said it was the most comfortable device they had ever slept on. I had three noncompliant CPAP patients stay on the VPAP Auto, and they are now 100% compliant," reported one respondent. Another stated, "The [VPAP] machine, like the S9 CPAP, is much easier to breathe against. We have seen an increase in patient compliance since